Prevalence and risk factors for selection of quinolone-resistant Escherichia coli strains in fecal flora of patients receiving quinolone therapy.
about
Prevalence, Risk Factors, and Clinical Relevance of Fluoroquinolone-Resistant Organisms in Rectal Cultures: Should We Target Antibiotic Prophylaxis Prior to Prostate Biopsy?Emergence of resistant Klebsiella pneumoniae in the intestinal tract during successful treatment of Klebsiella pneumoniae lung infection in rats.Therapeutic strategies for chemotherapy-induced neutropenia in patients with solid tumors.Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.Clinical importance and epidemiology of quinolone resistance.The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance.Global fluoroquinolone resistance epidemiology and implictions for clinical use.Do we really know the prevalence of multi-drug resistant Escherichia coli in the territorial and nosocomial population?Impact of antibiotic use during hospitalization on the development of gastrointestinal colonization with Escherichia coli with reduced fluoroquinolone susceptibility.Infection after transrectal ultrasound-guided prostate biopsy.Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients.Detection of fluoroquinolone-resistant organisms from rectal swabs by use of selective media prior to a transrectal prostate biopsy.Risk factor of community-onset spontaneous bacterial peritonitis caused by fluoroquinolone-resistant Escherichia coli in patients with cirrhosis.Risk factors for multidrug-resistant Escherichia coli rectal colonization of dogs on admission to a veterinary hospital.
P2860
Q26749124-1E3F208C-12A2-4490-B3C3-D227C0ED242CQ33962866-76ED4E95-5F9B-44DA-8E5B-F4774528AB14Q34670717-617F4DF3-0621-49E1-8B28-45F90E1A2EF8Q34737197-5B85B281-80AF-4E67-91E0-C3A264FA6980Q34838791-0CFFBCDA-1B11-4AFF-AB58-BE43B08F8C44Q35022526-76896CDA-6BA5-489E-A384-40A0EE7F6383Q35676675-A656B3A8-9E61-4B05-8328-4817EC08F3A3Q36337074-0DC28AA6-2BC7-4ECA-B712-CB065634C2F8Q36813752-239F3B5F-D747-40F7-9D9F-556B3D1A7F90Q37691788-F7580BD1-B018-4769-88C0-19B9633D1257Q38474665-C7FE095A-6AE4-4BC0-8FE4-32195CE7DA8BQ39456487-22A1D92D-85A4-4A89-B183-8A180DC0A74EQ41195981-5CAB02A2-E353-4039-8B71-A80162241213Q41516806-94D97258-226F-4ECA-963B-E5D79A5A7C40Q41972495-1E7D4494-E72C-4E17-9613-981654D4A1F6Q42239642-CC48B5B4-9968-4F6D-A49C-2E8E41B3E202Q54387434-05B0D8AC-ED47-44DD-B364-44CA13F48F87
P2860
Prevalence and risk factors for selection of quinolone-resistant Escherichia coli strains in fecal flora of patients receiving quinolone therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevalence and risk factors fo ...... s receiving quinolone therapy.
@en
Prevalence and risk factors fo ...... s receiving quinolone therapy.
@nl
type
label
Prevalence and risk factors fo ...... s receiving quinolone therapy.
@en
Prevalence and risk factors fo ...... s receiving quinolone therapy.
@nl
prefLabel
Prevalence and risk factors fo ...... s receiving quinolone therapy.
@en
Prevalence and risk factors fo ...... s receiving quinolone therapy.
@nl
P2093
P2860
P921
P356
P1476
Prevalence and risk factors fo ...... s receiving quinolone therapy.
@en
P2093
P2860
P304
P356
10.1128/AAC.01228-08
P407
P577
2008-12-08T00:00:00Z